Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis.

Date publication

janvier 2017

Journal

Alimentary pharmacology & therapeutics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Mao EJ, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27862107

Résumé

Crohn's disease (CD) and ulcerative colitis (UC) have a progressive course leading to hospitalisation and surgery. The ability of existing therapies to alter disease course is not clearly defined.

Mots clés

Biological Products, therapeutic use, Colitis, Ulcerative, diagnosis, Crohn Disease, diagnosis, Hospitalization, trends, Humans, Immunosuppressive Agents, therapeutic use, Randomized Controlled Trials as Topic, methods, Treatment Outcome

Référence

Aliment. Pharmacol. Ther.. 2017 01;45(1):3-13